Which food has more fairy dust, and which journalist will report it?

September 5th, 2010

In his now-famous New York Times magazine piece, Michael Pollan told us to “Eat food. Not too much. Mostly plants.”  What is often forgotten is that this was not a prescription for eating as much as it was an admonition against “nutritionism”, the idea that foods are nothing more than a vehicle for the delivery [...]
check out our ads below, they maybe of interest.

Virginia’s War on Academic Freedom

September 5th, 2010

The attorney general of Virginia sued his own state University in an attempt to quash science on global warming.
thanks for visiting today!

Dendreon Gets Some Respect

September 2nd, 2010

Pivotal Provenge results are published in the New England Journal of Medicine.
affordable coverage health insurance

Sanofi CEO Talks Merger Philosophy

September 2nd, 2010

Christopher Viehbacher talks about mergers in general, while declining to discuss the one everyone wants to know about.
Rome wasnt built in a day!

Scientists build a better salmon

September 2nd, 2010

Salmon may soon be the first genetically modified animal to hit our dinner plates. We’ve been eating GMO foods for years, mostly without noticing it, but until now all the genetically modified organisms have been plants.
The new salmon was developed by AquaBounty Technologies, a company in Massachusetts, and hereâ•’s how it works: start with Atlantic [...]
more to read in our archives

Pharma Stories You May Have Missed

September 2nd, 2010

A roundup of relevant posts from other blogs.
thats funny

Vitamin D: Still More Questions Than Answers

September 2nd, 2010

While we can draw some pretty safe conclusions about the prevention and treatment of some common bone diseases, it is too early to form any useful conclusions about other diseases such as cancer, influenza, or multiple sclerosis.
maybe this will change things

Acupuncture Infiltrates the University of Maryland and NEJM

September 2nd, 2010

A New England Journal of Medicine Article Promotes Pseudoscience
company cost health insurance low orlando

The Sad Truth About $100,000 Cancer Drugs

August 23rd, 2010

An important New Yorker story focuses on the unfortunate reality of rare, expensive treatments: they fail most of the time.
great news thought i would never see this.

Dendreon Gets Some Respect

August 23rd, 2010

Pivotal Provenge results are published in the New England Journal of Medicine.
great news thought i would never see this.